A Randomized Phase IIa Study of Vorinostat in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes: Preliminary Results
暂无分享,去创建一个
L. Silverman | S. Parmar | H. Kantarjian | G. Garcia-Manero | I. Gojo | A. Raza | S. Goldberg | J. Garcia-Vargas | L. Michaelis | K. Heath | S. Rizvi